You have 9 free searches left this month | for more free features.

Condition

Kidney Transplantation (1)

Multiple Sclerosis (1)

Newly Diagnosed With Type 1 Diabetes (1)

Patients Active and Listed for Lung Transplantation (1)

Overall Status

Completed (4)

Sign in for free

Phase

phase 2 (2)

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

Hoffmann-La Roche (1)

Indiana University School of Medicine (1)

Johns Hopkins University (1)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

Collaborator

Facet Biotech (1)

Pescovitz, Mark D., M.D. (1)

Roche Pharma AG (1)

Intervention

zenapax (4)

corticosteroids (1)

mycophenolate mofetil [cellcept] (1)

neoral (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (2)

Industry (1)

NIH (1)

Study Type

Interventional (4)

zenapax

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Newly Diagnosed With Type 1 Diabetes Trial in Indianapolis (Zenapax)

Completed

Newly Diagnosed With Type 1 Diabetes

Zenapax

Indianapolis, Indiana

Indiana University - Riley Hospital for Children

Aug 10, 2020

Patients Active and Listed for Lung Transplantation Trial in Baltimore (Zenapax)

Completed

Patients Active and Listed for Lung Transplantation

Zenapax

Baltimore, Maryland

Johns Hopkins University Hospital

Dec 21, 2017

Kidney Transplantation Trial in Worldwide (Corticosteroids, Neoral, Zenapax)

Completed

Kidney Transplantation

Corticosteroids
+3 more

Birmingham, Alabama
+35 more

Nov 1, 2016

Multiple Sclerosis Trial run by the NINDS (Zenapax)

Completed

Multiple Sclerosis

Zenapax

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Aug 4, 2011